Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 931-597-4 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- No data
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Non-GLP compliant, non-guideline experimental investigation. Study published in scientific, peer reviewed journal.
Data source
Reference
- Reference Type:
- publication
- Title:
- Acute pulmonary and systemic effects of inhaled coal fly ash in rats: comparison to ambient environmental particles.
- Author:
- Smith K R, Veranth J M, Kodavanti U P, et al.
- Year:
- 2 006
- Bibliographic source:
- Toxicol Sci. 93(2):390-9.
Materials and methods
- Principles of method if other than guideline:
- The effect of CFA on pulmonary and systemic inflammation and injury was measured in male Sprague-Dawley rats exposed to filtered air or CFA for 4 h/day for 3 days.
- GLP compliance:
- no
- Test type:
- other: in vivo
Test material
- Reference substance name:
- Coal fly ash
- EC Number:
- 924-417-0
- IUPAC Name:
- Coal fly ash
- Details on test material:
- The particulate material used for inhalation was derived from a bulk sample of fly ash collected by air pollution control equipment on a 400-MW power plant burning bituminous coal from multiple mines in the Wasatch Plateau, UT, USA, coal field. Size-fractionated material, enriched in 0.4- to 2-um sized particles, was extracted from the bulk fly ash by mechanical resuspension and aerodynamic separation. The capture efficiency of typical coal power plant air pollution control equipment is at a minimum for the size range of CFA particles used in the current study, but is still > 90%. Extracting particles in the minimum efficiency size range from captured power plant fly ash produces an aerosol similar to the emitted particles.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Forty-eight male Sprague-Dawley rats, 8 weeks of age (260– 270 g) and free of respiratory pathogens or disease, were purchased from Harlan (San Diego, CA). Prior to CFA exposure, animals were acclimated to nose-only exposure tubes for 5 days (2, 3, 4, 4, 4 h, on days 1–5, respectively). Animals were handled in accordance with standards established by the U.S. Animal Welfare Acts as set forth in the National Institutes of Health guidelines (Institute of Laboratory Animal Resources (1996) as well as the Animal Care and Use committee of the University of California, Davis. Rats were housed in plastic cages with TEK-Chip pelleted paper bedding (Harlan Teklad, Madison, WI) and maintained on a 12-h light/12-h dark cycle. All animals had access to water and Laboratory Rodent Diet 5001 (LabDiet, Brentwood, MO) ad libitum except during each daily acclimation or exposure period.
Administration / exposure
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose only
- Vehicle:
- other: filtered air
- Details on inhalation exposure:
- CFA was aerosolized using a belt feeder and fluidized bed system (Figure 1). PM2.5 size-fractionated particles were premixed with 100- to 200-um-diameter glass beads and loaded into a dust feed for delivery to a vibrating fluidized bed system for aerosolization of both CFA and glass beads. The aerosol subsequently passed through a cyclone separator to remove the glass beads, while the CFA remained aerosolized passing through a krypton-85 source (to reduce particle agglomeration) to the nose-only inhalation system.
- Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- Particle concentration during exposure was monitored by a continuous-reading, light-scattering, dust concentration monitor and filter connected to the exposure chamber. A Grimm Series 1.108 Aerosol Spectrometer (GRIMM Aerosol Technik GmbH, Douglasville, G
- Duration of exposure:
- 3 d
- Remarks on duration:
- 4h per day for 3 days
- Concentrations:
- 1400 ug/m3
- No. of animals per sex per dose:
- 5 – 6 per time point per group
- Control animals:
- yes
- Details on study design:
- Rats were exposed to filtered air or aerosolized CFA in a nose-only exposure system for 4 h/day for 3 days and examined 18 or 36 h after the last exposure to CFA. These necropsy times were selected to measure acute responses and to approximate the 1- to 3-day lag time between increases in PM concentration and human effects commonly observed in epidemiology studies.
- Statistics:
- All numerical data were calculated as the mean and standard deviation. Comparisons between animals exposed to CFA and filtered air were made by Student’s t-test or, where appropriate, by analysis of variance followed by Fisher’s protected least significant difference posttest. Comparisons were considered significant if a value of p < 0.05 was observed. Statistical analysis was performed with StatView 5.0.1 (SAS Institute, Inc., Cary, NC).
Results and discussion
- Mortality:
- No effects
- Clinical signs:
- other: No data
- Body weight:
- No data
- Gross pathology:
- No data
- Other findings:
- Total number of neutrophils in bronchoalveolar lavage fluid (BALF) following exposure to CFA was significantly increased along with significantly elevated blood neutrophils. Exposure to CFA caused slight increases in macrophage inflammatory protein-2, and marked increases in transferrin in BALF. Interleukin-1beta and total antioxidant potential in lung tissues were also increased in rats exposed to CFA. Histological examination of lung tissue demonstrated focal alveolar septal thickening and increased cellularity in select alveoli immediately beyond terminal bronchioles. These responses are consistent with the ability of CFA to induce mild neutrophilic inflammation in the lung and blood following short-term exposure at levels that could be occupationally relevant.
Any other information on results incl. tables
Exposure to CFA caused slight increases in macrophage inflammatory protein-2, and marked increases in transferrin in BALF. Interleukin-1beta and total antioxidant potential in lung tissues were also increased in rats exposed to CFA. Histological examination of lung tissue demonstrated focal alveolar septal thickening and increased cellularity in select alveoli immediately beyond terminal bronchioles.
Applicant's summary and conclusion
- Interpretation of results:
- other: no data
- Remarks:
- Criteria used for interpretation of results: other: no data
- Conclusions:
- When comparing the effects of CFA with those of concentrated ambient particles, CFA does not appear to have greater potency to cause pulmonary alterations.
- Executive summary:
The effect of CFA on pulmonary and systemic inflammation and injury was measured in male Sprague-Dawley rats exposed to filtered air or CFA for 4 h/day for 3 days. The average concentration of CFA particulate matter less than 2.5 microm (PM(2.5)) was 1400 microg/m(3), of which 600 microg/m(3) was PM(1). Animals were examined 18 and 36 h postexposure. Chemical analysis of CFA detected silicon, calcium, aluminum, and iron as major components. Total number of neutrophils in bronchoalveolar lavage fluid (BALF) following exposure to CFA was significantly increased along with significantly elevated blood neutrophils. Exposure to CFA caused slight increases in macrophage inflammatory protein-2, and marked increases in transferrin in BALF. Interleukin-1beta and total antioxidant potential in lung tissues were also increased in rats exposed to CFA. Histological examination of lung tissue demonstrated focal alveolar septal thickening and increased cellularity in select alveoli immediately beyond terminal bronchioles. These responses are consistent with the ability of CFA to induce mild neutrophilic inflammation in the lung and blood following short-term exposure at levels that could be occupationally relevant. However, when comparing the effects of CFA with those of concentrated ambient particles, CFA does not appear to have greater potency to cause pulmonary alterations.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.